Loading....
The Cancer Support Community is pleased to invite you to join us on December 9, 2021, from 1:00-2:00 pm ET for our Biomarker Testing for Lung Cancer Webinar.
Have you or your loved one been diagnosed with lung cancer? Do you want to learn about the latest treatment advancements? Join Cancer Support Community’s Rachel Saks, Senior Director of Education, in a webinar about biomarker testing for non-small cell or small cell lung cancer. Dr. Sanja Dacic of the University of Pittsburgh Medical Center Presbyterian Hospital will discuss biomarker testing for lung cancer and how it is being used to identify targeted therapy options based on your specific cancer subtype.
Sanja Dacic, MD, PhD, is a professor of pathology in the Department of Pathology at the University of Pittsburgh, Director of Anatomic Pathology at UPMC Presbyterian Hospital and Director of Thoracic Pathology Center of Excellence. Dr Dacic received her medical degree and a doctor of philosophy degree at the School of Medicine, University of Zagreb, in Zagreb, Croatia. She completed her residency training at the University of Pittsburgh and joined the faculty immediately after her fellowship in surgical pathology. Dr. Dacic is focused on diagnostic pulmonary and molecular pathology and has been involved in many basic and translational research projects in lung cancer and pleural mesotheliomas that have resulted in numerous peer-reviewed scientific articles, book chapters, and reviews. She was a co-author of the original and revised CAP/IASLC/ AMP guidelines for molecular testing in lung cancer. Dr. Dacic is a member of the Editorial Board for the upcoming 5th WHO Classification of Thoracic Tumors. She has been an officer of the Pulmonary Pathology Society since 2006 and is currently serving as president. Dr. Dacic is a member of the US and Canadian Mesothelioma Group and the International Mesothelioma Panel.
As a 501c3 organization, the Cancer Support Community does not endorse, represent or warrant the accuracy or reliability of any of the information obtained from third party sources. This presentation is for informational purposes only.
,